Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial.

Garland LL, Guillen-Rodriguez J, Hsu CH, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, Zhang X, Liu H, Liu G, Spira AE, Beane JE, Wojtowicz M, Chow HS.

Cancer Prev Res (Phila). 2019 Nov;12(11):809-820. doi: 10.1158/1940-6207.CAPR-19-0036. Epub 2019 Aug 26.

PMID:
31451521
2.

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis.

Almutairi AR, Alkhatib N, Martin J, Babiker HM, Garland LL, McBride A, Abraham I.

Crit Rev Oncol Hematol. 2019 Oct;142:16-25. doi: 10.1016/j.critrevonc.2019.07.004. Epub 2019 Jul 10. Review.

PMID:
31326706
3.

Regional Changes in Brain 18F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes.

Eshghi N, Garland LL, Choudhary G, Hsu CC, Eshghi A, Han J, Hamilton RJ, Krupinski E, Kuo PH.

J Nucl Med Technol. 2018 Dec;46(4):355-358. doi: 10.2967/jnmt.118.212316. Epub 2018 Aug 3.

PMID:
30076247
4.

Characterization of carfilzomib-resistant non-small cell lung cancer cell lines.

Hanke NT, Imler E, Marron MT, Seligmann BE, Garland LL, Baker AF.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1317-1327. doi: 10.1007/s00432-018-2662-0. Epub 2018 May 15.

PMID:
29766327
5.

18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer.

Eshghi N, Garland LL, Nia E, Betancourt R, Krupinski E, Kuo PH.

J Nucl Med Technol. 2018 Sep;46(3):260-264. doi: 10.2967/jnmt.117.204933. Epub 2018 Mar 29.

6.

Double-negative (CD27-IgD-) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations.

Centuori SM, Gomes CJ, Kim SS, Putnam CW, Larsen BT, Garland LL, Mount DW, Martinez JD.

J Transl Med. 2018 Feb 15;16(1):30. doi: 10.1186/s12967-018-1404-z.

7.

Incidence of Brain Metastases on Follow-up 18F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain?

Nia ES, Garland LL, Eshghi N, Nia BB, Avery RJ, Kuo PH.

J Nucl Med Technol. 2017 Sep;45(3):193-197. doi: 10.2967/jnmt.117.194571. Epub 2017 Jul 13.

8.

Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.

Hanke NT, Garland LL, Baker AF.

J Cancer Res Clin Oncol. 2016 Mar;142(3):549-60. doi: 10.1007/s00432-015-2047-6. Epub 2015 Sep 18.

9.

Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.

Baker AF, Hanke NT, Sands BJ, Carbajal L, Anderl JL, Garland LL.

J Exp Clin Cancer Res. 2014 Dec 31;33:111. doi: 10.1186/s13046-014-0111-8.

10.

SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).

Ou SH, Moon J, Garland LL, Mack PC, Testa JR, Tsao AS, Wozniak AJ, Gandara DR.

J Thorac Oncol. 2015 Feb;10(2):387-91. doi: 10.1097/JTO.0000000000000360.

11.

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.

Chow HH, Garland LL, Heckman-Stoddard BM, Hsu CH, Butler VD, Cordova CA, Chew WM, Cornelison TL.

J Transl Med. 2014 Aug 14;12:223. doi: 10.1186/s12967-014-0223-0.

12.

Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma.

Mount DW, Putnam CW, Centouri SM, Manziello AM, Pandey R, Garland LL, Martinez JD.

BMC Med Genomics. 2014 Jun 10;7:33. doi: 10.1186/1755-8794-7-33.

13.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B.

J Clin Oncol. 2013 Mar 1;31(7):895-902. doi: 10.1200/JCO.2011.40.1174. Epub 2013 Jan 22.

14.

Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman M, Gandara DR.

J Thorac Oncol. 2011 Nov;6(11):1938-45. doi: 10.1097/JTO.0b013e318229586e.

15.

Chemotherapy for malignant pleural mesothelioma.

Garland LL.

Curr Treat Options Oncol. 2011 Jun;12(2):181-8. doi: 10.1007/s11864-011-0152-6.

PMID:
21468683
16.

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS.

Cancer Prev Res (Phila). 2010 Sep;3(9):1168-75. doi: 10.1158/1940-6207.CAPR-09-0155. Epub 2010 Aug 17.

17.

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.

Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE.

Clin Cancer Res. 2007 Oct 15;13(20):6175-81.

18.

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.

Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJ, Testa JR, Altomare DA, Borden EC.

J Clin Oncol. 2007 Jun 10;25(17):2406-13.

PMID:
17557954
19.
20.

A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors.

Garland LL, Hidalgo M, Mendelson DS, Ryan DP, Arun BK, Lovalvo JL, Eiseman IA, Olson SC, Lenehan PF, Eder JP.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4274-82.

21.

Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy.

Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E.

J Pain Symptom Manage. 2004 Jul;28(1):7-18.

PMID:
15223080
22.

The National Cancer Institute Silicone Implant/Multiple Myeloma Registry.

Rabkin CS, Silverman S, Tricot G, Garland LL, Ballester O, Potter M.

Curr Top Microbiol Immunol. 1996;210:385-7. No abstract available.

PMID:
8565581
23.

Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk.

Garland LL, Ballester OF, Vasey FB, Benson K, Moscinski LC, Farmelo MJ, Rodriguez MJ, Rapaport DP.

Curr Top Microbiol Immunol. 1996;210:361-6. No abstract available.

PMID:
8565578

Supplemental Content

Loading ...
Support Center